Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.23.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenue $ 37 $ 59
Cost of revenue 23 54
Gross profit 14 5
Operating expenses:        
Research and development 490 1,473 1,031 2,568
Selling, general and administrative 4,409 3,002 7,985 6,474
Total operating expenses 4,899 4,475 9,016 9,042
Loss from operations (4,885) (4,475) (9,011) (9,042)
Other income (expense):        
Interest expense (2,508) (2) (4,525) (5)
Loss on extinguishment of warrant liability   (504)
Loss on extinguishment of debt (2,345)   (2,345)  
Gain on issuance of convertible notes 64
Change in fair value of warrants 2,130 7,736
Change in fair value of notes (6,883) (7,000)
Other expense (28) (1,234)
Total other income (expense) (9,634) (2) (7,808) (5)
Loss before income taxes (14,519) (4,477) (16,819) (9,047)
Income tax expense
Net loss (14,519) (4,477) (16,819) (9,047)
Deemed dividend on Series D preferred stock (6)
Net loss attributable to common stockholders $ (14,616) $ (4,477) $ (16,997) $ (9,047)
Net loss per share attributable to common stockholders (in Dollars per share) $ (18.02) $ (16.35) $ (25.96) $ (33.62)
Weighted average shares outstanding, basic (in Shares) 810,983 273,767 653,848 269,094
Series A Preferred Stock        
Other income (expense):        
Cumulative dividends $ (5) $ (9)
Series B Preferred Stock        
Other income (expense):        
Cumulative dividends (29) (49)
Series C Preferred Stock        
Other income (expense):        
Cumulative dividends (10) (10)
Series D Preferred Stock        
Other income (expense):        
Cumulative dividends $ (53) $ (84)